Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma

Name: Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma
License: Public Domain

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

locally advanced or metastatic esophageal squamous cell carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 279517
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.